Pitfalls in the Quest of Neuroprotectants for the Perinatal Brain

Pierre Gressèns(Inserm), Steven W. Levison(Rutgers, The State University of New Jersey), Sherly George(University of Auckland), Henrik Hagberg(Stockholm IVF), Carina Mallard(University of Gothenburg), Virginia Le Verche(Inserm), Laura Bennet(University of Auckland), Alistair J. Gunn(Starship Children's Health), Barbara C. Tilley(The University of Texas Health Science Center at Houston), Leslie Schwendimann(Inserm), Pascal Dournaud(Délégation Paris 7), Xiaoyang Wang(Third Affiliated Hospital of Zhengzhou University), Catherine I. Rousset(St Thomas' Hospital), Mhoyra Fraser(University of Auckland)
Developmental Neuroscience
January 1, 2011
10.1159/000333109
Cited by 13

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|JAMA|2015|2.5k
The role of inflammation in perinatal brain injury
|Nature Reviews Neurology|2015|811
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pro‐regenerative properties of cytokine‐activated astrocytes
|Journal of Neurochemistry|2004|468